Form 4 for AGL agilon health, inc.
Accepted 2026-01-13 00:00:00 ET · period of report 2026-01-10 · accession 0001628280-26-001979 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-13 | 2026-01-10 | AGL | Schwaneke Jeffrey A. | CFO | A - Grant | $0.00 | +600.0K | 1.68M | +56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-10 | A | A | 600,000 | $0.00 | 1,675,122 | D | — | — | (F1) Restricted stock units that vest in three equal installments on each anniversary of January 10, 2026. (F2) Includes restricted stock units. |